Series C Therapeutics Companies

BigHat Biosciences develops antibody and protein therapeutics using machine learning, synthetic biology, and automated experimentation.

Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, a condition that can affect tissues surrounding the eyes.

Allotera Therapeutics is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

Cyllene Therapeutics is a French biotechnology business that is pioneering a novel approach termed pinpoint gene therapy.

Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Cognito Therapeutics develops neurotechnology therapies to treat neurodegenerative diseases by stimulating specific brain activity patterns.

Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.

Ukko is a biotechnology company focused on developing immunotherapies for the treatment of allergies and other immune-mediated diseases.

Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.

Abcuro develops immunotherapies to treat autoimmunity and cancer.

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.